Optiver Holding
CAPR icon

Optiver Holding’s Capricor Therapeutics CAPR Stock Holding History

Optiver Holding’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.56K Sell
148
-117
-44% -$3.55K ﹤0.01% 2119
2026
Q1 		$8.06K Sell
265
-36
-12% -$959 ﹤0.01% 1271
2025
Q4 		$8.69K Sell
301
-37
-11% -$483 ﹤0.01% 1179
2025
Q3 		$2.44K Buy
+338
New +$2.49K ﹤0.01% 2305

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Optiver Holding's CAPR Position: Q2 2026 in Review

Optiver Holding reduced its Capricor Therapeutics (CAPR) stake by 44% in Q2 2026, selling an estimated $3.55K and leaving 148 shares worth $3.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2119.

Optiver Holding first reported a position in CAPR in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.69K in Q4 2025. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Optiver Holding held 148 shares of Capricor Therapeutics worth $3.56K as of Q2 2026.
  • Optiver Holding sold 117 Capricor Therapeutics shares in Q2 2026, an estimated $3.55K.
  • Capricor Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2119 holding.
  • Optiver Holding first reported a position in Capricor Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Capricor Therapeutics position peaked at $8.69K in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.